A pilot study of minocycline for the prevention of paclitaxel-associated neuropathy: ACCRU study RU221408I
ConclusionsResults of this pilot study do not support the use of minocycline to prevent CIPN, but suggest that it may reduce P-APS and decrease fatigue; further study of the impact of this agent on those endpoints may be warranted.
Source: Supportive Care in Cancer - Category: Cancer & Oncology Source Type: research
More News: Brain | Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Chronic Pain | Minocycline | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Neurology | Pain | Peripheral Neuropathy | Solodyn | Study | Toxicology